Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical betamethasone versus topical tacrolimus 0.1% for vitiligo
IRCT201311295605N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of betamethasone and tacrolimus in Vitiligo (2 arms), sponsored by Tabriz University of Medical Sciences. Started Oct 2013; status: completed.
02
Drugs
betamethasonetacrolimus
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT201311295605N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201311295605N6.